Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Capital Expenditures (2024 - 2026)

Beta Bionics' Capital Expenditures history spans 3 years, with the latest figure at $1.4 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures rose 313.51% to $1.4 million in Q1 2026 year-over-year; TTM through Mar 2026 was $6.3 million, a 90.88% increase, with the full-year FY2025 number at $5.3 million, up 56.02% from a year prior.
  • Capital Expenditures hit $1.4 million in Q1 2026 for Beta Bionics, down from $5.3 million in the prior quarter.
  • Over the last five years, Capital Expenditures for BBNX hit a ceiling of $5.3 million in Q4 2025 and a floor of -$232000.0 in Q2 2025.
  • Historically, Capital Expenditures has averaged $1.1 million across 3 years, with a median of $550000.0 in 2024.
  • The widest YoY moves for Capital Expenditures: up 837.43% in 2025, down 142.18% in 2025.
  • Tracing BBNX's Capital Expenditures over 3 years: stood at $561000.0 in 2024, then soared by 837.43% to $5.3 million in 2025, then plummeted by 73.82% to $1.4 million in 2026.
  • Business Quant data shows Capital Expenditures for BBNX at $1.4 million in Q1 2026, $5.3 million in Q4 2025, and -$63000.0 in Q3 2025.